Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Nutraceuticals--an emerging era in the treatment and prevention of cardiovascular diseases.
Ramaa CS, Shirode AR, Mundada AS, Kadam VJ. Ramaa CS, et al. Curr Pharm Biotechnol. 2006 Feb;7(1):15-23. doi: 10.2174/138920106775789647. Curr Pharm Biotechnol. 2006. PMID: 16472130 Review.
Editorial (Thematic Issue: Drug Reprofiling: An Alternative Path to Drug Discovery).
Ramaa CS. Ramaa CS. Curr Top Med Chem. 2016;16(19):2067-8. doi: 10.2174/156802661619160530204415. Curr Top Med Chem. 2016. PMID: 27297095 No abstract available.
A new dawn for the use of thiazolidinediones in cancer therapy.
Joshi H, Pal T, Ramaa CS. Joshi H, et al. Among authors: ramaa cs. Expert Opin Investig Drugs. 2014 Apr;23(4):501-10. doi: 10.1517/13543784.2014.884708. Epub 2014 Mar 6. Expert Opin Investig Drugs. 2014. PMID: 24597633 Review.
Design and development of oxazol-5-ones as potential partial PPAR-╬│ agonist against cancer cell lines.
Pal T, Joshi H, Ramaa CS. Pal T, et al. Among authors: ramaa cs. Anticancer Agents Med Chem. 2014;14(6):872-83. doi: 10.2174/1871520614666140528155118. Anticancer Agents Med Chem. 2014. PMID: 24875128
5-Benzylidene-2,4-thiazolidenedione derivatives: Design, synthesis and evaluation as inhibitors of angiogenesis targeting VEGR-2.
Bhanushali U, Rajendran S, Sarma K, Kulkarni P, Chatti K, Chatterjee S, Ramaa CS. Bhanushali U, et al. Among authors: ramaa cs. Bioorg Chem. 2016 Aug;67:139-47. doi: 10.1016/j.bioorg.2016.06.006. Epub 2016 Jun 30. Bioorg Chem. 2016. PMID: 27388635
Assorted Applications of N-substituted-2,4-thiazolidinediones in Various Pathological Conditions.
Gupta R, Joshi H, Ramaa CS. Gupta R, et al. Among authors: ramaa cs. Mini Rev Med Chem. 2019;19(4):346-360. doi: 10.2174/1389557518666171129163426. Mini Rev Med Chem. 2019. PMID: 29189151 Review.
Repositioning of Difluorinated Propanediones as Inhibitors of Histone Methyltransferases and their Biological Evaluation in Human Leukemic Cell Lines.
Pal T, Sharda A, Khade B, Ramaa CS, Gupta S. Pal T, et al. Among authors: ramaa cs. Anticancer Agents Med Chem. 2018;18(13):1892-1899. doi: 10.2174/1871520618666180404125721. Anticancer Agents Med Chem. 2018. PMID: 29623853
A novel series of di-fluorinated propanedione derivatives synergistically augment paclitaxel mediated caspase 3 activation in ovarian cancer cells.
Nagraj J, Chatterjee S, Pal T, Sakpal AS, Gota V, Ramaa CS, Ray P. Nagraj J, et al. Among authors: ramaa cs. J Cancer Res Ther. 2014 Jul-Sep;10(3):701-9. doi: 10.4103/0973-1482.138095. J Cancer Res Ther. 2014. PMID: 25313764
Hydroxy Cinnamic Acid Derivatives as Partial PPAR╬│ Agonists: In silico Studies, Synthesis and Biological Characterization Against Chronic Myeloid Leukemia Cell Line (K562).
Joshi H, Marulkar K, Gota V, Ramaa CS. Joshi H, et al. Among authors: ramaa cs. Anticancer Agents Med Chem. 2017;17(4):524-541. doi: 10.2174/1871520616666160607010156. Anticancer Agents Med Chem. 2017. PMID: 27291250
Novel Anthraquinone Derivatives as Dual Inhibitors of Topoisomerase 2 and Casein Kinase 2: In Silico Studies, Synthesis and Biological Evaluation on Leukemic Cell Lines.
Kabir A, Tilekar K, Upadhyay N, Ramaa CS. Kabir A, et al. Among authors: ramaa cs. Anticancer Agents Med Chem. 2018;18(11):1551-1562. doi: 10.2174/1871520618666180423111309. Anticancer Agents Med Chem. 2018. PMID: 29683096
19 results
Jump to page